These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15618850

  • 1. Treatment of refractory post-transjugular portosystemic stent-shunt encephalopathy: a novel case of stent luminal reduction.
    Clarke G, Patel R, Tsao S, Blanshard K.
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1387-90. PubMed ID: 15618850
    [Abstract] [Full Text] [Related]

  • 2. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
    Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC.
    Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
    [Abstract] [Full Text] [Related]

  • 3. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.
    Kochar N, Tripathi D, McAvoy NC, Ireland H, Redhead DN, Hayes PC.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):294-303. PubMed ID: 19086235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC.
    J Hepatol; 1995 Aug 01; 23(2):123-8. PubMed ID: 7499782
    [Abstract] [Full Text] [Related]

  • 6. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions.
    Khan F, Tripathi D.
    World J Gastroenterol; 2021 Nov 28; 27(44):7612-7624. PubMed ID: 34908802
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D, Ferguson J, Barkell H, Macbeth K, Ireland H, Redhead DN, Hayes PC.
    Eur J Gastroenterol Hepatol; 2006 Mar 28; 18(3):225-32. PubMed ID: 16462534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
    Maleux G, Verslype C, Heye S, Wilms G, Marchal G, Nevens F.
    AJR Am J Roentgenol; 2007 Mar 28; 188(3):659-64. PubMed ID: 17312051
    [Abstract] [Full Text] [Related]

  • 12. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Mar 28; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 13. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M, Lüthen R, Cohnen M, von Wrisberg F, Mödder U, Häussinger D.
    Zentralbl Chir; 2005 Jun 28; 130(3):246-9. PubMed ID: 15965878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G.
    J Hepatol; 2017 Sep 28; 67(3):508-516. PubMed ID: 28506905
    [Abstract] [Full Text] [Related]

  • 16. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
    Krieger S, Jauss M, Jansen O, Stiehl A, Sauer P, Geissler M, Theilmann L, Krieger D.
    J Hepatol; 1997 Jul 28; 27(1):121-6. PubMed ID: 9252084
    [Abstract] [Full Text] [Related]

  • 17. Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre.
    Tripathi D, Helmy A, Macbeth K, Balata S, Lui HF, Stanley AJ, Redhead DN, Hayes PC.
    Eur J Gastroenterol Hepatol; 2004 Jan 28; 16(1):9-18. PubMed ID: 15095847
    [Abstract] [Full Text] [Related]

  • 18. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K, Carrion AF, Martin P, Vaheesan K, Salsamendi J, Doshi M, Yrizarry JM.
    Liver Int; 2015 Dec 28; 35(12):2487-94. PubMed ID: 26332169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments.
    Tripathi D, Redhead D.
    Eur J Gastroenterol Hepatol; 2006 Nov 28; 18(11):1127-33. PubMed ID: 17033430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.